» Articles » PMID: 21063023

The Tetraspanin CD9 Regulates Migration, Adhesion, and Homing of Human Cord Blood CD34+ Hematopoietic Stem and Progenitor Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2010 Nov 11
PMID 21063023
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

The stromal cell-derived factor-1 (SDF-1)/chemokine C-X-C receptor 4 (CXCR4) axis plays a critical role in homing and engraftment of hematopoietic stem/progenitor cells (HSCs) during bone marrow transplantation. To investigate the transcriptional regulation provided by this axis, we performed the first differential transcriptome profiling of human cord blood CD34(+) cells in response to short-term exposure to SDF-1 and identified a panel of genes with putative homing functions. We demonstrated that CD9, a member of the tetraspanin family of proteins, was expressed in CD34(+)CD38(-/lo) and CD34(+)CD38(+) cells. CD9 levels were enhanced by SDF-1, which simultaneously down-regulated CXCR4 membrane expression. Using specific inhibitors and activators, we demonstrated that CD9 expression was modulated via CXCR4, G-protein, protein kinase C, phospholipase C, extracellular signal-regulated kinase, and Janus kinase 2 signals. Pretreatment of CD34(+) cells with the anti-CD9 monoclonal antibody ALB6 significantly inhibited SDF-1-mediated transendothelial migration and calcium mobilization, whereas adhesion to fibronectin and endothelial cells was enhanced. Pretreatment of CD34(+) cells with ALB6 significantly impaired their homing to bone marrow and spleen of sublethally irradiated NOD/SCID (nonobese diabetic/severe combined immune-deficient) mice. Sorted CD34(+)CD9(-) cells displayed lower bone marrow homing capacity compared with that of total CD34(+) cells. CD9 expression on homed CD34(+) cells was significantly up-regulated in vivo. Our results indicate that CD9 might possess specific functions in HSC homing.

Citing Articles

Selected stem cell populations in pediatric acute lymphoblastic leukemia.

Kretowska-Grunwald A, Sawicka-Zukowska M, Starosz A, Krawczuk-Rybak M, Moniuszko M, Grubczak K Front Immunol. 2024; 15:1446687.

PMID: 39386216 PMC: 11461207. DOI: 10.3389/fimmu.2024.1446687.


Tviblindi algorithm identifies branching developmental trajectories of human B-cell development and describes abnormalities in RAG-1 and WAS patients.

Bakardjieva M, Pelak O, Wentink M, Glier H, Novak D, Stancikova J Eur J Immunol. 2024; 54(12):e2451004.

PMID: 39235410 PMC: 11628918. DOI: 10.1002/eji.202451004.


Integrin α2 is an early marker for osteoclast differentiation that contributes to key steps in osteoclastogenesis.

Brockhaus K, Hemsen I, Jauch-Speer S, Niland S, Vogl T, Eble J Front Cell Dev Biol. 2024; 12:1448725.

PMID: 39220682 PMC: 11363192. DOI: 10.3389/fcell.2024.1448725.


CD9 shapes glucocorticoid sensitivity in pediatric B-cell precursor acute lymphoblastic leukemia.

Zhang C, Chan K, Ng W, Cheung J, Sun Q, Wang H Haematologica. 2024; 109(9):2833-2845.

PMID: 38572553 PMC: 11367191. DOI: 10.3324/haematol.2023.282952.


Cutting Edge: The Tetraspanin CD53 Promotes CXCR4 Signaling and Bone Marrow Homing in B Cells.

Chakraborty M, Greenberg Z, Dong Q, Roundy N, Bednarski J, Paracatu L J Immunol. 2024; 212(7):1075-1080.

PMID: 38363205 PMC: 10948292. DOI: 10.4049/jimmunol.2300336.